CEFALY Marks a Milestone: #1 Neuromodulation Device Prescribed by Veterans Health Administration Providers
DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the...
Brain
Connecticut Innovations Invests $11.3 Million in Early-Stage Companies in Q1 FY26
Deals leveraged $86.9 million in outside capital in the first quarter of the fiscal year NEW HAVEN, Conn., Nov. 3,...
All In for Awareness: November Marks National Epilepsy Awareness Month
BOWIE, Md., Nov. 3, 2025 /PRNewswire/ -- The Epilepsy Foundation of America (EFA) is calling on people across the country...
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US – European Market Put at $7 Billion
November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient...
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug...
Snke Unveils SnkeXR, the First Medical Grade, Open Platform AR Glasses for Healthcare
Augmented Reality Glasses Purpose-Built for the Medical Technology IndustryMUNICH & HYATTSVILLE, Md.--(BUSINESS WIRE)--#AIHealthcare--MDIC Medical XR Summit – Snke OS GmbH...
Brainomix Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions CHICAGO and OXFORD, England, Oct. 31, 2025 /PRNewswire/ --...
GITEX GLOBAL 2025: Record international participation and outcome-driven dialogues close landmark 45th edition
Unprecedented global turnout defined 2025 edition as 6,800 tech enterprises, 2,000 startups, 1,200 investors, and tech representatives from 180 nations...
ChemDiv’s Discovery Platform Enables Differentiated, Reversible Pan‑EGFR Kinase Inhibitors for GFR‑Mutant Lung Cancer
Upgraded design + synthesis engine targets broad mutant coverage with wild‑type EGFR sparing; active collaboration advances toward scale‑up and CMC...
Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting
HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
HOUSTON, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in...
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - October...
Platform that connects older adults, caregivers and families wins national competition
MONTREAL, Oct. 29, 2025 /CNW/ - Canadian startup Root & Seed has won the 2025 AGE-WELL National Impact Challenge: Implementing...
Apollo Biowellness, Inc., Corporate Status and Merger Update
North Bergen, New Jersey--(Newsfile Corp. - October 29, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to...
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty...
Strategic Shift: Patient Experience Now Healthcare’s Top C-Suite Priority
New Report reveals that 101 hospital and health system leaders prioritize digital health and virtual care to improve access and...
Luminopia Collaborates with Crunchyroll to Continue Building Its Extensive Content Library for Pediatric Lazy Eye Patients
Kids using Luminopia can now watch popular anime shows, further diversifying their content selection CAMBRIDGE, Mass., Oct. 28, 2025...
Liberty Advisor Group Employees Volunteer with Shirley Ryan AbilityLab
CHICAGO, Oct. 28, 2025 /PRNewswire/ -- Employees from Liberty Advisor Group (Liberty), a premier management consulting firm that helps clients tackle...
BrainCo Bionic Hand Inspires a Child’s Journey Forward
BOSTON, Oct. 28, 2025 /PRNewswire/ -- In early September, a young boy named Ma received a brand-new hand — a...